Global.afinitor.com

Global AFINITOR. (everolimus) Tablets for TSC-seizures, SEGA with TSC, & Renal Angiomyolipoma with TSC. See full prescribing & safety info.

Today's Global.afinitor.com headlines: Observe fresh posts and updates on Global AFINITOR. Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Global.afinitor.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Global AFINITOR

Subscribe to related news

Breast Cancer Drugs in Late-Stage Development/Recently Approved
via newdrugapprovals.wordpress

The article is 2012-2013 based and reader discretion is sought to ascertian the stage of approval Afinitor® (everolimus) http://newdrugapprovals.wordpress.com/2013/04/27/drug-spotlight-afinitor-everolimus-novartis/ Sponsor: Novartis Method...
Novartis drug Afinitor® significantly improves progression-free survival in advanced nonfunctional gastrointestinal and ...
via worldnews

In pivotal study, everolimus reduced risk of disease progression by 52%; showed 11.0-month median progression-free survival vs 3.9 months for placebo[1] Advanced, progressive, nonfunctional neuroendocrine tumors of GI or lung origin are rare forms of...
Drug Interactions and the Pharmacist: Focus on Everolimus
via theannals

OBJECTIVE: To evaluate everolimus drug-drug and drug-food interactions, with an emphasis on patients with cancer. DATA SOURCES: Literature was accessed through PubMed (1990-March 2013) using Boolean combinations of the terms drug interactions, herb...
Press Announcements > FDA approves first drug formulated for children with rare brain tumor
via elbiruniblogspotcom.blogspot

Press Announcements > FDA approves first drug formulated for children with rare brain tumor FDA NEWS RELEASE For Immediate Release: Aug. 29, 2012 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO...
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma
via theoncologist.alphamedpress

The oral multikinase inhibitor sunitinib malate was approved by the U.S. Food and Drug Administration in January 2006 for use in patients with advanced renal cell carcinoma (RCC). Since then, it has been approved globally for this indication and for...

Global.afinitor.com popular pages

AFINITOR® for TSC seizures, SEGA, and Renal Angiomyolipoma

Get HCP information on AFINITOR® (everolimus) Tablets for TSC-seizures, SEGA with TSC, & Renal Angiomyolipoma with TSC. See full prescribing & safety info.
AFINITOR® for TSC seizures, SEGA, and Renal Angiomyolipoma

IMPORTANT SAFETY INFORMATION AFINITOR® (everolimus) Tablets and AFINITOR DISPERZ® (everolimus tablets for oral suspension) are contraindicated in patients with hypersensitivity to everolimus, to other...